Tirofiban Hydrochloride for Injection
Indication
Tirofiban combined with heparin is indicated for the prevention of myocardial ischemic events in patients with unstable angina or non-Q wave myocardial infarction. It is also indicated for the prevention of cardiac ischemic complications associated with sudden occlusion of the treated coronary artery in patients with coronary ischemic syndrome undergoing coronary angioplasty or intracoronary plaque resection.
Packaging Specification
5 mg (as tirofiban)
Manufacturer
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
-
Founded in:
1992-12-31 -
Address:
No. 866, Moganshan Road, Gongshu District, Hangzhou City, Zhejiang Province -
Tax NO.:
91330100609120774J -
Registered Funds:
872.30813 million yuan -
Website:
-
Email: